Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Khalid Badwan, MD

Advertisement

Articles by Khalid Badwan, MD

Recurrent stone disease: Steps for practical management

ByKhalid Badwan, MD,Ramakrishna Venkatesh, MD
November 1st 2006

Between 30% and 60% of calcium oxalate stone patients have hypercalciuria in the absence of raised serum calcium levels.

Advertisement

Latest Updated Articles

  • Recurrent stone disease: Steps for practical management
    Recurrent stone disease: Steps for practical management

    Published: November 1st 2006 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

Study validates diagnostic performance of CxBladder Triage Plus Test

2

Pearls & Perspectives: Research Innovations in Sexual Medicine

3

FDA grants breakthrough device designation to diagnostic test for cUTIs

4

Evan Panken, MD, on patient preferences for urologist gender in vasectomy care

5

Real-world insights into treating metastatic castration-sensitive prostate cancer

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us